Your session is about to expire
← Back to Search
SUPPORT online platform for people with type 1 diabetes for Diabetes Mellitus (SUPPORT Trial)
SUPPORT Trial Summary
This trial will test a web-based training platform to see if it is more effective than the current system in teaching people with type 1 diabetes how to use new therapies and technologies to reduce the fear and frequency of hypoglycemia.
- Type 1 Diabetes Mellitus With Hypoglycemia
SUPPORT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SUPPORT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have other health conditions that make it difficult for you to manage your diabetes or use the platform, such as dementia or blindness.
- Group 1: Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it still possible for participants to sign up for this research endeavor?
"Current records on clinicaltrials.gov are suggesting that this study is not presently admitting applicants, despite first being published in February 5th 2020 and last updated 6 months ago. Fortunately, there are still 1299 other medical trials actively seeking participants."
What aims is this research endeavor attempting to accomplish?
"The primary goal of the trial, which is to be evaluated after 6 months in duration, will assess patient's fear of hypoglycemia. Assessing secondary objectives include: measuring participants' knowledge about diabetes self-management via an online questionnaire; quantifying dietary behaviours including frequency of snacks for physical activity and number consumed for hypoglycemia prevention; and counting the amount nocturnal hypoglycemic episodes endured by patients during a single month."
Share this study with friends
Copy Link
Messenger